Skip to content
CG
  • Home
  • About
  • Services
  • Blog
  • Careers
  • Contact
    Contact

Drug-eluting contact lens for glaucoma

Blog_1 / 03/17/2021 03/17/2021

The trial evaluating MediPrint™ Ophthalmics’  LLT-BMT1 – a drug-eluting contact lens being developed to treat glaucoma has been completed, showing safe and tolerable results as well as reduction of hyperaemia.

 

Check the article out here: Drug-eluting contact lens shows potential in first-in-human study (europeanpharmaceuticalreview.com)

 

Post navigation
← Previous Post
Next Post →
Organization
  • Barcelona HQ office
  • Barcelona: (+34) 936 690 575
  • Madrid: (+34) 936 690 575
  • info@clementine.global
  • www.clementine.global
Policies
  • Legal Notice
  • Privacy Policy
  • Cookie Policy
Other Links
  • EMA Europe
  • FDA USA
  • NMPA China
Social Responsibility
  • SCIF Nepal

Clementine Global S.L. supports the charity organization Spinal Cord Injury Foundation Nepal dedicated to enhance quality of people living with disabilities. 

Copyright © 2023 CG